---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-296658"
form_type: "8-K"
ticker: "AMRX"
cik: "0001723128"
company_name: "Amneal Pharmaceuticals, Inc."
filed_at: "2023-12-15T23:59:59+00:00"
generated_at: "2026-06-07T11:58:47.813013+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Amneal to transfer stock exchange listing from NYSE to Nasdaq effective Dec 27, 2023

## Summary
- Listing on NYSE ends at market close Dec 26; Nasdaq trading starts at market open Dec 27.
- Common stock will continue to trade under symbol AMRX and join Nasdaq Composite and Nasdaq Biotechnology Index.
- Voluntary delisting from NYSE approved by Board; no change in business operations or shareholder rights.

## SEC filing metadata
- accession: 0001193125-23-296658
- form_type: 8-K
- ticker: AMRX
- cik: 0001723128
- company_name: Amneal Pharmaceuticals, Inc.
- filed_at: 2023-12-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1723128/000119312523296658/0001193125-23-296658-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1723128/000119312523296658/d65273d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-296658
- JSON: https://secwatch.observer/filing/0001193125-23-296658.json
- Plain text: https://secwatch.observer/filing/0001193125-23-296658.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.